iwCLL 2023 | The racial disparities between treatment availability for patients with CLL
Adam Kittai, MD, Ohio State University, Columbus, OH, discusses the disparity in patient outcomes between black and white patients with chronic lymphocytic leukemia (CLL), but clarifies that black patients have the same response to treatment when they are treated for the disease. Dr Kittai also elaborates on the genotypic markers often seen in black patients with CLL.
This interview took place at the 20th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Abbvie: Consultancy; Astrazeneca: Consultancy, Research Funding; Beigene: Consultancy; Janssen: Consultancy.
